TW201130977A - Mesenchymal stem cells (MSCs) isolated from mobilized peripheral blood - Google Patents

Mesenchymal stem cells (MSCs) isolated from mobilized peripheral blood Download PDF

Info

Publication number: TW201130977A
Authority: TW; Taiwan
Prior art keywords: peripheral blood; individual; csf; cells; msc
Prior art date: 2009-12-04

Application number

TW099142522A

Other languages

English (en)

Chinese (zh)

Inventor

Wayne Marasco

Satish Medicetty

Yajuan Jiang

Original Assignee

Neostem Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-12-04

Filing date

2010-12-06

Publication date

2011-09-16

2010-12-06 Application filed by Neostem Inc filed Critical Neostem Inc

2010-12-06 Priority to TW099142522A priority Critical patent/TW201130977A/zh

2011-09-16 Publication of TW201130977A publication Critical patent/TW201130977A/zh

Links

239000011886 peripheral blood Substances 0.000 title claims abstract description 351
210000005259 peripheral blood Anatomy 0.000 title claims abstract description 350
210000002901 mesenchymal stem cell Anatomy 0.000 title claims description 590
238000000034 method Methods 0.000 claims abstract description 244
210000000130 stem cell Anatomy 0.000 claims abstract description 175
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims abstract description 153
102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims abstract description 153
230000001483 mobilizing effect Effects 0.000 claims abstract description 49
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims abstract 10
102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims abstract 10
210000004027 cell Anatomy 0.000 claims description 429
239000003795 chemical substances by application Substances 0.000 claims description 78
210000004369 blood Anatomy 0.000 claims description 51
239000008280 blood Substances 0.000 claims description 50
238000011282 treatment Methods 0.000 claims description 45
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 40
238000000926 separation method Methods 0.000 claims description 40
201000010099 disease Diseases 0.000 claims description 38
230000001965 increasing effect Effects 0.000 claims description 20
102100032912 CD44 antigen Human genes 0.000 claims description 19
101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 19
101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims description 19
102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims description 19
238000000338 in vitro Methods 0.000 claims description 19
238000004091 panning Methods 0.000 claims description 16
238000002560 therapeutic procedure Methods 0.000 claims description 16
230000001172 regenerating effect Effects 0.000 claims description 15
101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 claims description 14
102100025304 Integrin beta-1 Human genes 0.000 claims description 14
102100022464 5'-nucleotidase Human genes 0.000 claims description 13
101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 claims description 13
210000004504 adult stem cell Anatomy 0.000 claims description 12
206010036790 Productive cough Diseases 0.000 claims description 11
210000003802 sputum Anatomy 0.000 claims description 11
208000024794 sputum Diseases 0.000 claims description 11
238000002955 isolation Methods 0.000 claims description 10
108050003558 Interleukin-17 Proteins 0.000 claims description 8
102000013691 Interleukin-17 Human genes 0.000 claims description 8
230000002093 peripheral effect Effects 0.000 claims description 8
238000010187 selection method Methods 0.000 claims description 8
238000005534 hematocrit Methods 0.000 claims description 7
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 7
239000002458 cell surface marker Substances 0.000 claims description 6
210000001671 embryonic stem cell Anatomy 0.000 claims description 6
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 6
229910052737 gold Inorganic materials 0.000 claims description 6
239000010931 gold Substances 0.000 claims description 6
229930012538 Paclitaxel Natural products 0.000 claims description 5
229960001592 paclitaxel Drugs 0.000 claims description 5
ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims description 2
238000002617 apheresis Methods 0.000 claims description 2
229960003668 docetaxel Drugs 0.000 claims description 2
238000002372 labelling Methods 0.000 claims description 2
241000218691 Cupressaceae Species 0.000 claims 1
230000000903 blocking effect Effects 0.000 claims 1
229910052594 sapphire Inorganic materials 0.000 claims 1
239000010980 sapphire Substances 0.000 claims 1
239000002689 soil Substances 0.000 claims 1
210000001185 bone marrow Anatomy 0.000 abstract description 91
238000001727 in vivo Methods 0.000 abstract description 16
210000004271 bone marrow stromal cell Anatomy 0.000 abstract description 10
210000003995 blood forming stem cell Anatomy 0.000 abstract description 5
230000001105 regulatory effect Effects 0.000 abstract description 2
239000000523 sample Substances 0.000 description 97
239000000203 mixture Substances 0.000 description 62
210000001519 tissue Anatomy 0.000 description 52
108090000623 proteins and genes Proteins 0.000 description 50
230000004069 differentiation Effects 0.000 description 36
239000002609 medium Substances 0.000 description 35
210000003958 hematopoietic stem cell Anatomy 0.000 description 31
150000001875 compounds Chemical class 0.000 description 28
102000004169 proteins and genes Human genes 0.000 description 28
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 27
239000000047 product Substances 0.000 description 27
239000003814 drug Substances 0.000 description 26
206010017076 Fracture Diseases 0.000 description 24
238000003860 storage Methods 0.000 description 23
239000000243 solution Substances 0.000 description 20
230000000694 effects Effects 0.000 description 19
102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 18
101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 18
101000958041 Homo sapiens Musculin Proteins 0.000 description 18
210000000988 bone and bone Anatomy 0.000 description 18
230000014509 gene expression Effects 0.000 description 18
102000046949 human MSC Human genes 0.000 description 18
230000008569 process Effects 0.000 description 18
208000010392 Bone Fractures Diseases 0.000 description 17
208000027418 Wounds and injury Diseases 0.000 description 17
239000007788 liquid Substances 0.000 description 17
210000000056 organ Anatomy 0.000 description 17
238000002659 cell therapy Methods 0.000 description 16
230000006870 function Effects 0.000 description 16
238000012360 testing method Methods 0.000 description 16
108010002386 Interleukin-3 Proteins 0.000 description 15
102000000646 Interleukin-3 Human genes 0.000 description 15
241001465754 Metazoa Species 0.000 description 15
238000003556 assay Methods 0.000 description 15
229940076264 interleukin-3 Drugs 0.000 description 15
230000035755 proliferation Effects 0.000 description 15
230000035876 healing Effects 0.000 description 14
239000007924 injection Substances 0.000 description 14
238000002347 injection Methods 0.000 description 14
238000005138 cryopreservation Methods 0.000 description 13
229940079593 drug Drugs 0.000 description 13
210000000265 leukocyte Anatomy 0.000 description 13
239000000126 substance Substances 0.000 description 13
238000002054 transplantation Methods 0.000 description 13
102100027286 Fanconi anemia group C protein Human genes 0.000 description 12
101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 12
102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 12
210000003714 granulocyte Anatomy 0.000 description 12
238000001990 intravenous administration Methods 0.000 description 12
150000007523 nucleic acids Chemical class 0.000 description 12
241000282412 Homo Species 0.000 description 11
206010052428 Wound Diseases 0.000 description 11
238000004458 analytical method Methods 0.000 description 11
230000008859 change Effects 0.000 description 11
210000002540 macrophage Anatomy 0.000 description 11
230000001225 therapeutic effect Effects 0.000 description 11
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
150000001413 amino acids Chemical class 0.000 description 10
239000012595 freezing medium Substances 0.000 description 10
239000010410 layer Substances 0.000 description 10
YIQPUIGJQJDJOS-UHFFFAOYSA-N plerixafor Chemical compound C=1C=C(CN2CCNCCCNCCNCCC2)C=CC=1CN1CCCNCCNCCCNCC1 YIQPUIGJQJDJOS-UHFFFAOYSA-N 0.000 description 10
239000000725 suspension Substances 0.000 description 10
230000029663 wound healing Effects 0.000 description 10
OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 9
102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 9
239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 9
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 9
230000001464 adherent effect Effects 0.000 description 9
238000004113 cell culture Methods 0.000 description 9
239000000306 component Substances 0.000 description 9
230000006378 damage Effects 0.000 description 9
230000007774 longterm Effects 0.000 description 9
239000003550 marker Substances 0.000 description 9
102000039446 nucleic acids Human genes 0.000 description 9
108020004707 nucleic acids Proteins 0.000 description 9
230000007170 pathology Effects 0.000 description 9
229960002169 plerixafor Drugs 0.000 description 9
239000002243 precursor Substances 0.000 description 9
230000008439 repair process Effects 0.000 description 9
210000002966 serum Anatomy 0.000 description 9
238000007920 subcutaneous administration Methods 0.000 description 9
108091006905 Human Serum Albumin Proteins 0.000 description 8
102000008100 Human Serum Albumin Human genes 0.000 description 8
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 8
238000009472 formulation Methods 0.000 description 8
239000003102 growth factor Substances 0.000 description 8
238000001802 infusion Methods 0.000 description 8
108020004999 messenger RNA Proteins 0.000 description 8
230000037361 pathway Effects 0.000 description 8
239000002953 phosphate buffered saline Substances 0.000 description 8
241000894007 species Species 0.000 description 8
108010073385 Fibrin Proteins 0.000 description 7
102000009123 Fibrin Human genes 0.000 description 7
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 7
102000000589 Interleukin-1 Human genes 0.000 description 7
108010002352 Interleukin-1 Proteins 0.000 description 7
-1 Stro-1 Proteins 0.000 description 7
210000002798 bone marrow cell Anatomy 0.000 description 7
230000001413 cellular effect Effects 0.000 description 7
210000001175 cerebrospinal fluid Anatomy 0.000 description 7
210000002808 connective tissue Anatomy 0.000 description 7
210000003743 erythrocyte Anatomy 0.000 description 7
229950003499 fibrin Drugs 0.000 description 7
239000012530 fluid Substances 0.000 description 7
239000000499 gel Substances 0.000 description 7
238000009396 hybridization Methods 0.000 description 7
238000004519 manufacturing process Methods 0.000 description 7
239000000463 material Substances 0.000 description 7
210000003716 mesoderm Anatomy 0.000 description 7
210000003205 muscle Anatomy 0.000 description 7
210000000440 neutrophil Anatomy 0.000 description 7
230000001575 pathological effect Effects 0.000 description 7
230000004044 response Effects 0.000 description 7
238000012216 screening Methods 0.000 description 7
230000004936 stimulating effect Effects 0.000 description 7
238000010257 thawing Methods 0.000 description 7
238000012546 transfer Methods 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
102000004127 Cytokines Human genes 0.000 description 6
108090000695 Cytokines Proteins 0.000 description 6
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 6
102000004890 Interleukin-8 Human genes 0.000 description 6
108090001007 Interleukin-8 Proteins 0.000 description 6
206010028980 Neoplasm Diseases 0.000 description 6
108091034117 Oligonucleotide Proteins 0.000 description 6
239000004698 Polyethylene Substances 0.000 description 6
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
201000011510 cancer Diseases 0.000 description 6
230000003833 cell viability Effects 0.000 description 6
238000001816 cooling Methods 0.000 description 6
238000007667 floating Methods 0.000 description 6
239000012634 fragment Substances 0.000 description 6
210000001654 germ layer Anatomy 0.000 description 6
208000014674 injury Diseases 0.000 description 6
229940096397 interleukin-8 Drugs 0.000 description 6
XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 6
210000001616 monocyte Anatomy 0.000 description 6
102000040430 polynucleotide Human genes 0.000 description 6
108091033319 polynucleotide Proteins 0.000 description 6
239000002157 polynucleotide Substances 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
230000000750 progressive effect Effects 0.000 description 6
239000000758 substrate Substances 0.000 description 6
CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 5
239000000427 antigen Substances 0.000 description 5
108091007433 antigens Proteins 0.000 description 5
102000036639 antigens Human genes 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
210000000601 blood cell Anatomy 0.000 description 5
210000001772 blood platelet Anatomy 0.000 description 5
230000004663 cell proliferation Effects 0.000 description 5
210000001612 chondrocyte Anatomy 0.000 description 5
238000012258 culturing Methods 0.000 description 5
229960004397 cyclophosphamide Drugs 0.000 description 5
230000007613 environmental effect Effects 0.000 description 5
210000003979 eosinophil Anatomy 0.000 description 5
108020001507 fusion proteins Proteins 0.000 description 5
102000037865 fusion proteins Human genes 0.000 description 5
230000002068 genetic effect Effects 0.000 description 5
230000012010 growth Effects 0.000 description 5
239000001963 growth medium Substances 0.000 description 5
230000036541 health Effects 0.000 description 5
208000015181 infectious disease Diseases 0.000 description 5
229910052757 nitrogen Inorganic materials 0.000 description 5
210000004940 nucleus Anatomy 0.000 description 5
210000000963 osteoblast Anatomy 0.000 description 5
239000000546 pharmaceutical excipient Substances 0.000 description 5
239000002504 physiological saline solution Substances 0.000 description 5
230000009467 reduction Effects 0.000 description 5
150000003839 salts Chemical class 0.000 description 5
239000011780 sodium chloride Substances 0.000 description 5
210000000952 spleen Anatomy 0.000 description 5
239000006228 supernatant Substances 0.000 description 5
108091023037 Aptamer Proteins 0.000 description 4
108010039209 Blood Coagulation Factors Proteins 0.000 description 4
102000015081 Blood Coagulation Factors Human genes 0.000 description 4
206010017088 Fracture nonunion Diseases 0.000 description 4
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
241001529936 Murinae Species 0.000 description 4
230000004913 activation Effects 0.000 description 4
210000001789 adipocyte Anatomy 0.000 description 4
230000003321 amplification Effects 0.000 description 4
238000010171 animal model Methods 0.000 description 4
230000008901 benefit Effects 0.000 description 4
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
238000001574 biopsy Methods 0.000 description 4
239000003114 blood coagulation factor Substances 0.000 description 4
210000001124 body fluid Anatomy 0.000 description 4
239000010839 body fluid Substances 0.000 description 4
210000004413 cardiac myocyte Anatomy 0.000 description 4
210000000845 cartilage Anatomy 0.000 description 4
230000024245 cell differentiation Effects 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
230000001684 chronic effect Effects 0.000 description 4
230000002338 cryopreservative effect Effects 0.000 description 4
238000001514 detection method Methods 0.000 description 4
210000003981 ectoderm Anatomy 0.000 description 4
210000001900 endoderm Anatomy 0.000 description 4
210000004700 fetal blood Anatomy 0.000 description 4
238000000684 flow cytometry Methods 0.000 description 4
230000003394 haemopoietic effect Effects 0.000 description 4
230000002757 inflammatory effect Effects 0.000 description 4
150000002484 inorganic compounds Chemical class 0.000 description 4
229910010272 inorganic material Inorganic materials 0.000 description 4
230000002175 menstrual effect Effects 0.000 description 4
238000000386 microscopy Methods 0.000 description 4
230000035772 mutation Effects 0.000 description 4
210000002569 neuron Anatomy 0.000 description 4
238000003199 nucleic acid amplification method Methods 0.000 description 4
238000005457 optimization Methods 0.000 description 4
150000002894 organic compounds Chemical class 0.000 description 4
108090000765 processed proteins & peptides Proteins 0.000 description 4
238000011084 recovery Methods 0.000 description 4
239000012679 serum free medium Substances 0.000 description 4
150000003384 small molecules Chemical class 0.000 description 4
206010006002 Bone pain Diseases 0.000 description 3
108010012236 Chemokines Proteins 0.000 description 3
102000019034 Chemokines Human genes 0.000 description 3
208000035473 Communicable disease Diseases 0.000 description 3
108020004414 DNA Proteins 0.000 description 3
108091060211 Expressed sequence tag Proteins 0.000 description 3
231100000111 LD50 Toxicity 0.000 description 3
241000124008 Mammalia Species 0.000 description 3
241000699670 Mus sp. Species 0.000 description 3
108091028043 Nucleic acid sequence Proteins 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
241000239226 Scorpiones Species 0.000 description 3
208000013201 Stress fracture Diseases 0.000 description 3
102000036693 Thrombopoietin Human genes 0.000 description 3
108010041111 Thrombopoietin Proteins 0.000 description 3
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
239000000853 adhesive Substances 0.000 description 3
230000001070 adhesive effect Effects 0.000 description 3
210000000577 adipose tissue Anatomy 0.000 description 3
239000000556 agonist Substances 0.000 description 3
230000000735 allogeneic effect Effects 0.000 description 3
230000001580 bacterial effect Effects 0.000 description 3
239000012503 blood component Substances 0.000 description 3
230000010478 bone regeneration Effects 0.000 description 3
239000000872 buffer Substances 0.000 description 3
150000001720 carbohydrates Chemical class 0.000 description 3
235000014633 carbohydrates Nutrition 0.000 description 3
230000000747 cardiac effect Effects 0.000 description 3
239000006285 cell suspension Substances 0.000 description 3
150000005829 chemical entities Chemical class 0.000 description 3
238000002512 chemotherapy Methods 0.000 description 3
238000011109 contamination Methods 0.000 description 3
235000005911 diet Nutrition 0.000 description 3
230000037213 diet Effects 0.000 description 3
239000003085 diluting agent Substances 0.000 description 3
238000010790 dilution Methods 0.000 description 3
239000012895 dilution Substances 0.000 description 3
239000002552 dosage form Substances 0.000 description 3
239000000975 dye Substances 0.000 description 3
230000003511 endothelial effect Effects 0.000 description 3
239000002158 endotoxin Substances 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
230000001747 exhibiting effect Effects 0.000 description 3
239000007789 gas Substances 0.000 description 3
238000010353 genetic engineering Methods 0.000 description 3
210000004602 germ cell Anatomy 0.000 description 3
239000008103 glucose Substances 0.000 description 3
238000002513 implantation Methods 0.000 description 3
230000001976 improved effect Effects 0.000 description 3
210000002570 interstitial cell Anatomy 0.000 description 3
238000007918 intramuscular administration Methods 0.000 description 3
238000007912 intraperitoneal administration Methods 0.000 description 3
229920006008 lipopolysaccharide Polymers 0.000 description 3
239000011159 matrix material Substances 0.000 description 3
238000005259 measurement Methods 0.000 description 3
238000002493 microarray Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000000877 morphologic effect Effects 0.000 description 3
229930014626 natural product Natural products 0.000 description 3
210000005036 nerve Anatomy 0.000 description 3
230000002974 pharmacogenomic effect Effects 0.000 description 3
210000002826 placenta Anatomy 0.000 description 3
102000004196 processed proteins & peptides Human genes 0.000 description 3
102000005962 receptors Human genes 0.000 description 3
108020003175 receptors Proteins 0.000 description 3
210000002460 smooth muscle Anatomy 0.000 description 3
239000007787 solid Substances 0.000 description 3
238000001228 spectrum Methods 0.000 description 3
239000003381 stabilizer Substances 0.000 description 3
210000002536 stromal cell Anatomy 0.000 description 3
239000007929 subcutaneous injection Substances 0.000 description 3
230000004083 survival effect Effects 0.000 description 3
208000024891 symptom Diseases 0.000 description 3
230000009885 systemic effect Effects 0.000 description 3
238000012549 training Methods 0.000 description 3
230000032258 transport Effects 0.000 description 3
239000003981 vehicle Substances 0.000 description 3
108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
206010001935 American trypanosomiasis Diseases 0.000 description 2
102000008076 Angiogenic Proteins Human genes 0.000 description 2
108010074415 Angiogenic Proteins Proteins 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
241000282472 Canis lupus familiaris Species 0.000 description 2
235000002566 Capsicum Nutrition 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
238000002965 ELISA Methods 0.000 description 2
108010029961 Filgrastim Proteins 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
102000003886 Glycoproteins Human genes 0.000 description 2
108090000288 Glycoproteins Proteins 0.000 description 2
ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
206010019233 Headaches Diseases 0.000 description 2
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 2
108090001030 Lipoproteins Proteins 0.000 description 2
102000004895 Lipoproteins Human genes 0.000 description 2
102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 2
206010028813 Nausea Diseases 0.000 description 2
241001494479 Pecora Species 0.000 description 2
241000758706 Piperaceae Species 0.000 description 2
108010076504 Protein Sorting Signals Proteins 0.000 description 2
241000700159 Rattus Species 0.000 description 2
101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 description 2
108020004511 Recombinant DNA Proteins 0.000 description 2
108010083644 Ribonucleases Proteins 0.000 description 2
102000006382 Ribonucleases Human genes 0.000 description 2
206010072170 Skin wound Diseases 0.000 description 2
108020004459 Small interfering RNA Proteins 0.000 description 2
241000282887 Suidae Species 0.000 description 2
102000040945 Transcription factor Human genes 0.000 description 2
108091023040 Transcription factor Proteins 0.000 description 2
241000223109 Trypanosoma cruzi Species 0.000 description 2
108090000631 Trypsin Proteins 0.000 description 2
102000004142 Trypsin Human genes 0.000 description 2
241000251539 Vertebrata <Metazoa> Species 0.000 description 2
241000700605 Viruses Species 0.000 description 2
230000009471 action Effects 0.000 description 2
239000004480 active ingredient Substances 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
230000032683 aging Effects 0.000 description 2
229940035676 analgesics Drugs 0.000 description 2
239000000730 antalgic agent Substances 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
230000003367 anti-collagen effect Effects 0.000 description 2
239000002260 anti-inflammatory agent Substances 0.000 description 2
229940121363 anti-inflammatory agent Drugs 0.000 description 2
230000001754 anti-pyretic effect Effects 0.000 description 2
239000003146 anticoagulant agent Substances 0.000 description 2
229940127219 anticoagulant drug Drugs 0.000 description 2
239000002221 antipyretic Substances 0.000 description 2
229940125716 antipyretic agent Drugs 0.000 description 2
230000006907 apoptotic process Effects 0.000 description 2
238000003491 array Methods 0.000 description 2
238000011130 autologous cell therapy Methods 0.000 description 2
239000011324 bead Substances 0.000 description 2
230000003115 biocidal effect Effects 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
238000010322 bone marrow transplantation Methods 0.000 description 2
239000011575 calcium Substances 0.000 description 2
239000006143 cell culture medium Substances 0.000 description 2
239000002771 cell marker Substances 0.000 description 2
210000000170 cell membrane Anatomy 0.000 description 2
230000012292 cell migration Effects 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
230000004087 circulation Effects 0.000 description 2
239000002299 complementary DNA Substances 0.000 description 2
239000012141 concentrate Substances 0.000 description 2
235000008504 concentrate Nutrition 0.000 description 2
238000009833 condensation Methods 0.000 description 2
230000005494 condensation Effects 0.000 description 2
230000001276 controlling effect Effects 0.000 description 2
230000034994 death Effects 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
230000007547 defect Effects 0.000 description 2
230000002950 deficient Effects 0.000 description 2
238000013461 design Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
208000035475 disorder Diseases 0.000 description 2
238000004090 dissolution Methods 0.000 description 2
238000009826 distribution Methods 0.000 description 2
230000007717 exclusion Effects 0.000 description 2
206010016256 fatigue Diseases 0.000 description 2
230000008175 fetal development Effects 0.000 description 2
238000001415 gene therapy Methods 0.000 description 2
229960001031 glucose Drugs 0.000 description 2
235000011187 glycerol Nutrition 0.000 description 2
210000000224 granular leucocyte Anatomy 0.000 description 2
231100000869 headache Toxicity 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
210000000777 hematopoietic system Anatomy 0.000 description 2
229920000669 heparin Polymers 0.000 description 2
229960002897 heparin Drugs 0.000 description 2
210000003494 hepatocyte Anatomy 0.000 description 2
239000012676 herbal extract Substances 0.000 description 2
238000007901 in situ hybridization Methods 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
238000007913 intrathecal administration Methods 0.000 description 2
238000010253 intravenous injection Methods 0.000 description 2
235000015110 jellies Nutrition 0.000 description 2
239000008274 jelly Substances 0.000 description 2
230000003902 lesion Effects 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
210000004185 liver Anatomy 0.000 description 2
210000004698 lymphocyte Anatomy 0.000 description 2
239000006166 lysate Substances 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
210000003593 megakaryocyte Anatomy 0.000 description 2
230000005012 migration Effects 0.000 description 2
238000013508 migration Methods 0.000 description 2
235000013336 milk Nutrition 0.000 description 2
239000008267 milk Substances 0.000 description 2
210000004080 milk Anatomy 0.000 description 2
210000005087 mononuclear cell Anatomy 0.000 description 2
208000025113 myeloid leukemia Diseases 0.000 description 2
210000000107 myocyte Anatomy 0.000 description 2
230000008693 nausea Effects 0.000 description 2
229940029345 neupogen Drugs 0.000 description 2
230000001537 neural effect Effects 0.000 description 2
210000001178 neural stem cell Anatomy 0.000 description 2
230000001722 neurochemical effect Effects 0.000 description 2
210000004967 non-hematopoietic stem cell Anatomy 0.000 description 2
125000003729 nucleotide group Chemical group 0.000 description 2
230000000399 orthopedic effect Effects 0.000 description 2
238000007911 parenteral administration Methods 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
210000004976 peripheral blood cell Anatomy 0.000 description 2
230000003836 peripheral circulation Effects 0.000 description 2
239000002831 pharmacologic agent Substances 0.000 description 2
210000001778 pluripotent stem cell Anatomy 0.000 description 2
102000054765 polymorphisms of proteins Human genes 0.000 description 2
239000000843 powder Substances 0.000 description 2
210000001236 prokaryotic cell Anatomy 0.000 description 2
230000002062 proliferating effect Effects 0.000 description 2
230000001737 promoting effect Effects 0.000 description 2
238000004445 quantitative analysis Methods 0.000 description 2
238000010188 recombinant method Methods 0.000 description 2
238000005057 refrigeration Methods 0.000 description 2
230000010076 replication Effects 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
230000036573 scar formation Effects 0.000 description 2
230000028327 secretion Effects 0.000 description 2
238000004062 sedimentation Methods 0.000 description 2
230000019491 signal transduction Effects 0.000 description 2
210000003491 skin Anatomy 0.000 description 2
210000004872 soft tissue Anatomy 0.000 description 2
239000002904 solvent Substances 0.000 description 2
230000002269 spontaneous effect Effects 0.000 description 2
238000010186 staining Methods 0.000 description 2
238000007619 statistical method Methods 0.000 description 2
239000008174 sterile solution Substances 0.000 description 2
230000035882 stress Effects 0.000 description 2
238000010254 subcutaneous injection Methods 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
230000008093 supporting effect Effects 0.000 description 2
238000001356 surgical procedure Methods 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
239000006188 syrup Substances 0.000 description 2
235000020357 syrup Nutrition 0.000 description 2
231100001274 therapeutic index Toxicity 0.000 description 2
230000000451 tissue damage Effects 0.000 description 2
231100000827 tissue damage Toxicity 0.000 description 2
230000017423 tissue regeneration Effects 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
230000002588 toxic effect Effects 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
238000001890 transfection Methods 0.000 description 2
239000012588 trypsin Substances 0.000 description 2
210000004881 tumor cell Anatomy 0.000 description 2
210000003954 umbilical cord Anatomy 0.000 description 2
239000013598 vector Substances 0.000 description 2
239000013603 viral vector Substances 0.000 description 2
239000011782 vitamin Substances 0.000 description 2
229940088594 vitamin Drugs 0.000 description 2
229930003231 vitamin Natural products 0.000 description 2
235000013343 vitamin Nutrition 0.000 description 2
LGLVVVCSQBZONM-HCCLCSBVSA-N (2r)-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentano Chemical compound NC(N)=NCCC[C@@H](NC(=O)C)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CCCN=C(N)N)C(N)=O LGLVVVCSQBZONM-HCCLCSBVSA-N 0.000 description 1
CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
PUAQLLVFLMYYJJ-UHFFFAOYSA-N 2-aminopropiophenone Chemical compound CC(N)C(=O)C1=CC=CC=C1 PUAQLLVFLMYYJJ-UHFFFAOYSA-N 0.000 description 1
208000030507 AIDS Diseases 0.000 description 1
108010051457 Acid Phosphatase Proteins 0.000 description 1
102000013563 Acid Phosphatase Human genes 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
244000144730 Amygdalus persica Species 0.000 description 1
101100100054 Arabidopsis thaliana TPLATE gene Proteins 0.000 description 1
241000531806 Aramus guarauna Species 0.000 description 1
BHELIUBJHYAEDK-OAIUPTLZSA-N Aspoxicillin Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3[C@H](C(C)(C)S[C@@H]32)C(O)=O)=O)NC(=O)[C@H](N)CC(=O)NC)=CC=C(O)C=C1 BHELIUBJHYAEDK-OAIUPTLZSA-N 0.000 description 1
208000023275 Autoimmune disease Diseases 0.000 description 1
208000013883 Blast injury Diseases 0.000 description 1
108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
102100022525 Bone morphogenetic protein 6 Human genes 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
210000003771 C cell Anatomy 0.000 description 1
108010061299 CXCR4 Receptors Proteins 0.000 description 1
102000012000 CXCR4 Receptors Human genes 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
208000024172 Cardiovascular disease Diseases 0.000 description 1
208000024699 Chagas disease Diseases 0.000 description 1
108010077544 Chromatin Proteins 0.000 description 1
108090000317 Chymotrypsin Proteins 0.000 description 1
208000032544 Cicatrix Diseases 0.000 description 1
206010053567 Coagulopathies Diseases 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
241000938605 Crocodylia Species 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
238000009007 Diagnostic Kit Methods 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
108010022894 Euchromatin Proteins 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
102100037362 Fibronectin Human genes 0.000 description 1
108010067306 Fibronectins Proteins 0.000 description 1
238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
241000233866 Fungi Species 0.000 description 1
108060005986 Granzyme Proteins 0.000 description 1
102000001398 Granzyme Human genes 0.000 description 1
206010018910 Haemolysis Diseases 0.000 description 1
239000012981 Hank's balanced salt solution Substances 0.000 description 1
206010019237 Healing abnormal Diseases 0.000 description 1
206010019280 Heart failures Diseases 0.000 description 1
208000002250 Hematologic Neoplasms Diseases 0.000 description 1
101000899390 Homo sapiens Bone morphogenetic protein 6 Proteins 0.000 description 1
101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 1
101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 1
101000835093 Homo sapiens Transferrin receptor protein 1 Proteins 0.000 description 1
241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
102100021592 Interleukin-7 Human genes 0.000 description 1
108010002586 Interleukin-7 Proteins 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 description 1
102000001846 Low Density Lipoprotein Receptor-Related Protein-2 Human genes 0.000 description 1
108010015372 Low Density Lipoprotein Receptor-Related Protein-2 Proteins 0.000 description 1
102000009571 Macrophage Inflammatory Proteins Human genes 0.000 description 1
108010009474 Macrophage Inflammatory Proteins Proteins 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
208000034578 Multiple myelomas Diseases 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
241000699660 Mus musculus Species 0.000 description 1
101100335081 Mus musculus Flt3 gene Proteins 0.000 description 1
108010021466 Mutant Proteins Proteins 0.000 description 1
102000008300 Mutant Proteins Human genes 0.000 description 1
241000204031 Mycoplasma Species 0.000 description 1
201000003793 Myelodysplastic syndrome Diseases 0.000 description 1
108010056642 N-alpha-acetyl-nona-D-arginine amide acetate Proteins 0.000 description 1
CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
229920002274 Nalgene Polymers 0.000 description 1
206010029260 Neuroblastoma Diseases 0.000 description 1
238000000636 Northern blotting Methods 0.000 description 1
108010038807 Oligopeptides Proteins 0.000 description 1
102000015636 Oligopeptides Human genes 0.000 description 1
108700020796 Oncogene Proteins 0.000 description 1
102000043276 Oncogene Human genes 0.000 description 1
241000366596 Osiris Species 0.000 description 1
208000002193 Pain Diseases 0.000 description 1
206010057249 Phagocytosis Diseases 0.000 description 1
206010035226 Plasma cell myeloma Diseases 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
241000219000 Populus Species 0.000 description 1
101710150336 Protein Rex Proteins 0.000 description 1
102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 1
108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 1
235000006040 Prunus persica var persica Nutrition 0.000 description 1
239000012980 RPMI-1640 medium Substances 0.000 description 1
208000006265 Renal cell carcinoma Diseases 0.000 description 1
208000017442 Retinal disease Diseases 0.000 description 1
206010038923 Retinopathy Diseases 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
206010061363 Skeletal injury Diseases 0.000 description 1
208000002152 Splenic rupture Diseases 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
108010045306 T134 peptide Proteins 0.000 description 1
108010025037 T140 peptide Proteins 0.000 description 1
108700012920 TNF Proteins 0.000 description 1
102100038126 Tenascin Human genes 0.000 description 1
206010043276 Teratoma Diseases 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
102100026144 Transferrin receptor protein 1 Human genes 0.000 description 1
108700019146 Transgenes Proteins 0.000 description 1
GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
230000002745 absorbent Effects 0.000 description 1
239000002250 absorbent Substances 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
230000003679 aging effect Effects 0.000 description 1
230000029936 alkylation Effects 0.000 description 1
238000005804 alkylation reaction Methods 0.000 description 1
208000030961 allergic reaction Diseases 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
239000003708 ampul Substances 0.000 description 1
239000002870 angiogenesis inducing agent Substances 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
238000005899 aromatization reaction Methods 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
230000003416 augmentation Effects 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
238000010923 batch production Methods 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
229940064804 betadine Drugs 0.000 description 1
210000001109 blastomere Anatomy 0.000 description 1
238000004820 blood count Methods 0.000 description 1
229940125691 blood product Drugs 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
230000037396 body weight Effects 0.000 description 1
210000002449 bone cell Anatomy 0.000 description 1
238000009583 bone marrow aspiration Methods 0.000 description 1
229940112869 bone morphogenetic protein Drugs 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
108010054191 butyrylesterase Proteins 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000002775 capsule Substances 0.000 description 1
210000003321 cartilage cell Anatomy 0.000 description 1
238000013354 cell banking Methods 0.000 description 1
230000022131 cell cycle Effects 0.000 description 1
230000011712 cell development Effects 0.000 description 1
230000032823 cell division Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000006037 cell lysis Effects 0.000 description 1
230000008668 cellular reprogramming Effects 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000013043 chemical agent Substances 0.000 description 1
238000007385 chemical modification Methods 0.000 description 1
239000002975 chemoattractant Substances 0.000 description 1
210000003483 chromatin Anatomy 0.000 description 1
208000022371 chronic pain syndrome Diseases 0.000 description 1
229960002376 chymotrypsin Drugs 0.000 description 1
210000003040 circulating cell Anatomy 0.000 description 1
239000007979 citrate buffer Substances 0.000 description 1
238000005352 clarification Methods 0.000 description 1
210000003109 clavicle Anatomy 0.000 description 1
230000035602 clotting Effects 0.000 description 1
230000004186 co-expression Effects 0.000 description 1
239000000701 coagulant Substances 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
239000000515 collagen sponge Substances 0.000 description 1
230000001332 colony forming effect Effects 0.000 description 1
238000010835 comparative analysis Methods 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
239000008139 complexing agent Substances 0.000 description 1
238000002591 computed tomography Methods 0.000 description 1
238000004590 computer program Methods 0.000 description 1
230000009073 conformational modification Effects 0.000 description 1
239000002872 contrast media Substances 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
210000000695 crystalline len Anatomy 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
238000004163 cytometry Methods 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
230000002354 daily effect Effects 0.000 description 1
238000007405 data analysis Methods 0.000 description 1
230000032459 dedifferentiation Effects 0.000 description 1
230000008260 defense mechanism Effects 0.000 description 1
238000000151 deposition Methods 0.000 description 1
210000004207 dermis Anatomy 0.000 description 1
238000011161 development Methods 0.000 description 1
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
AYXBAIULRDEVAS-UHFFFAOYSA-N dimethyl-[[4-[[3-(4-methylphenyl)-8,9-dihydro-7h-benzo[7]annulene-6-carbonyl]amino]phenyl]methyl]-(oxan-4-yl)azanium;iodide Chemical compound [I-].C1=CC(C)=CC=C1C1=CC=C(CCCC(=C2)C(=O)NC=3C=CC(C[N+](C)(C)C4CCOCC4)=CC=3)C2=C1 AYXBAIULRDEVAS-UHFFFAOYSA-N 0.000 description 1
SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
238000005553 drilling Methods 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
238000004043 dyeing Methods 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
230000002526 effect on cardiovascular system Effects 0.000 description 1
230000002500 effect on skin Effects 0.000 description 1
235000013601 eggs Nutrition 0.000 description 1
210000002308 embryonic cell Anatomy 0.000 description 1
238000002674 endoscopic surgery Methods 0.000 description 1
210000003038 endothelium Anatomy 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
210000000632 euchromatin Anatomy 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
238000011124 ex vivo culture Methods 0.000 description 1
230000005284 excitation Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000000284 extract Substances 0.000 description 1
210000003414 extremity Anatomy 0.000 description 1
208000030533 eye disease Diseases 0.000 description 1
210000004709 eyebrow Anatomy 0.000 description 1
210000002436 femur neck Anatomy 0.000 description 1
239000012894 fetal calf serum Substances 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
210000003754 fetus Anatomy 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
239000000945 filler Substances 0.000 description 1
238000011049 filling Methods 0.000 description 1
238000001914 filtration Methods 0.000 description 1
108700014844 flt3 ligand Proteins 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
230000005714 functional activity Effects 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
238000002309 gasification Methods 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
238000010363 gene targeting Methods 0.000 description 1
238000007429 general method Methods 0.000 description 1
230000002518 glial effect Effects 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
239000008187 granular material Substances 0.000 description 1
210000003128 head Anatomy 0.000 description 1
230000005802 health problem Effects 0.000 description 1
230000009033 hematopoietic malignancy Effects 0.000 description 1
230000008588 hemolysis Effects 0.000 description 1
230000011132 hemopoiesis Effects 0.000 description 1
210000003897 hepatic stem cell Anatomy 0.000 description 1
125000000623 heterocyclic group Chemical group 0.000 description 1
229920006158 high molecular weight polymer Polymers 0.000 description 1
230000001744 histochemical effect Effects 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
238000001794 hormone therapy Methods 0.000 description 1
102000046157 human CSF2 Human genes 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
238000005286 illumination Methods 0.000 description 1
238000010166 immunofluorescence Methods 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
238000011532 immunohistochemical staining Methods 0.000 description 1
230000006872 improvement Effects 0.000 description 1
229910052738 indium Inorganic materials 0.000 description 1
230000006698 induction Effects 0.000 description 1
239000011261 inert gas Substances 0.000 description 1
230000008595 infiltration Effects 0.000 description 1
238000001764 infiltration Methods 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
239000003978 infusion fluid Substances 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
229940102223 injectable solution Drugs 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
229940100994 interleukin-7 Drugs 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
238000001361 intraarterial administration Methods 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
239000007928 intraperitoneal injection Substances 0.000 description 1
238000007914 intraventricular administration Methods 0.000 description 1
NBQNWMBBSKPBAY-UHFFFAOYSA-N iodixanol Chemical compound IC=1C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C(I)C=1N(C(=O)C)CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NBQNWMBBSKPBAY-UHFFFAOYSA-N 0.000 description 1
229960004359 iodixanol Drugs 0.000 description 1
230000007794 irritation Effects 0.000 description 1
208000028867 ischemia Diseases 0.000 description 1
230000000302 ischemic effect Effects 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
108010013469 leridistim Proteins 0.000 description 1
229950003059 leridistim Drugs 0.000 description 1
239000002502 liposome Substances 0.000 description 1
238000004811 liquid chromatography Methods 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
210000003141 lower extremity Anatomy 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
210000003738 lymphoid progenitor cell Anatomy 0.000 description 1
239000003120 macrolide antibiotic agent Substances 0.000 description 1
208000002780 macular degeneration Diseases 0.000 description 1
210000001161 mammalian embryo Anatomy 0.000 description 1
210000004373 mandible Anatomy 0.000 description 1
230000000873 masking effect Effects 0.000 description 1
238000004949 mass spectrometry Methods 0.000 description 1
230000005541 medical transmission Effects 0.000 description 1
238000002483 medication Methods 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
229910052753 mercury Inorganic materials 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
239000011325 microbead Substances 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
108010032806 molgramostim Proteins 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
239000000178 monomer Substances 0.000 description 1
PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 1
229940074923 mozobil Drugs 0.000 description 1
210000004877 mucosa Anatomy 0.000 description 1
210000002464 muscle smooth vascular Anatomy 0.000 description 1
210000001665 muscle stem cell Anatomy 0.000 description 1
206010028537 myelofibrosis Diseases 0.000 description 1
230000002107 myocardial effect Effects 0.000 description 1
208000010125 myocardial infarction Diseases 0.000 description 1
210000004165 myocardium Anatomy 0.000 description 1
210000000822 natural killer cell Anatomy 0.000 description 1
230000001338 necrotic effect Effects 0.000 description 1
239000013642 negative control Substances 0.000 description 1
210000000276 neural tube Anatomy 0.000 description 1
210000004498 neuroglial cell Anatomy 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
231100000956 nontoxicity Toxicity 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
238000011580 nude mouse model Methods 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
210000004248 oligodendroglia Anatomy 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
230000008520 organization Effects 0.000 description 1
150000002902 organometallic compounds Chemical class 0.000 description 1
230000002188 osteogenic effect Effects 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
239000012188 paraffin wax Substances 0.000 description 1
244000045947 parasite Species 0.000 description 1
244000052769 pathogen Species 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
230000008807 pathological lesion Effects 0.000 description 1
HQQSBEDKMRHYME-UHFFFAOYSA-N pefloxacin mesylate Chemical compound [H+].CS([O-])(=O)=O.C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCN(C)CC1 HQQSBEDKMRHYME-UHFFFAOYSA-N 0.000 description 1
108010044644 pegfilgrastim Proteins 0.000 description 1
229960001373 pegfilgrastim Drugs 0.000 description 1
239000008188 pellet Substances 0.000 description 1
239000000816 peptidomimetic Substances 0.000 description 1
230000010412 perfusion Effects 0.000 description 1
210000001428 peripheral nervous system Anatomy 0.000 description 1
230000008782 phagocytosis Effects 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000012071 phase Substances 0.000 description 1
230000035790 physiological processes and functions Effects 0.000 description 1
239000000902 placebo Substances 0.000 description 1
229940068196 placebo Drugs 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
230000004983 pleiotropic effect Effects 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
239000013641 positive control Substances 0.000 description 1
230000004481 post-translational protein modification Effects 0.000 description 1
230000002980 postoperative effect Effects 0.000 description 1
238000004321 preservation Methods 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
230000037452 priming Effects 0.000 description 1
238000004393 prognosis Methods 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
238000001814 protein method Methods 0.000 description 1
238000000575 proteomic method Methods 0.000 description 1
238000003908 quality control method Methods 0.000 description 1
230000005855 radiation Effects 0.000 description 1
238000001959 radiotherapy Methods 0.000 description 1
239000013643 reference control Substances 0.000 description 1
239000013074 reference sample Substances 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
238000007634 remodeling Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
210000001525 retina Anatomy 0.000 description 1
238000012340 reverse transcriptase PCR Methods 0.000 description 1
238000012552 review Methods 0.000 description 1
231100000241 scar Toxicity 0.000 description 1
230000037387 scars Effects 0.000 description 1
238000005204 segregation Methods 0.000 description 1
239000002453 shampoo Substances 0.000 description 1
230000011664 signaling Effects 0.000 description 1
239000002356 single layer Substances 0.000 description 1
210000002027 skeletal muscle Anatomy 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
210000001988 somatic stem cell Anatomy 0.000 description 1
238000010183 spectrum analysis Methods 0.000 description 1
239000007921 spray Substances 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
210000004500 stellate cell Anatomy 0.000 description 1
210000000603 stem cell niche Anatomy 0.000 description 1
238000009168 stem cell therapy Methods 0.000 description 1
238000009580 stem-cell therapy Methods 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
210000003699 striated muscle Anatomy 0.000 description 1
125000000547 substituted alkyl group Chemical group 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
239000013589 supplement Substances 0.000 description 1
230000001502 supplementing effect Effects 0.000 description 1
239000000829 suppository Substances 0.000 description 1
210000005222 synovial tissue Anatomy 0.000 description 1
238000007910 systemic administration Methods 0.000 description 1
230000008685 targeting Effects 0.000 description 1
229940095064 tartrate Drugs 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
229940035024 thioglycerol Drugs 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
229940033618 tisseel Drugs 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
238000011830 transgenic mouse model Methods 0.000 description 1
238000013519 translation Methods 0.000 description 1
238000011269 treatment regimen Methods 0.000 description 1
230000002476 tumorcidal effect Effects 0.000 description 1
230000000381 tumorigenic effect Effects 0.000 description 1
210000000623 ulna Anatomy 0.000 description 1
210000001364 upper extremity Anatomy 0.000 description 1
210000000626 ureter Anatomy 0.000 description 1
210000003708 urethra Anatomy 0.000 description 1
210000003932 urinary bladder Anatomy 0.000 description 1
230000002485 urinary effect Effects 0.000 description 1
201000002282 venous insufficiency Diseases 0.000 description 1
210000002845 virion Anatomy 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1
230000037314 wound repair Effects 0.000 description 1
210000000707 wrist Anatomy 0.000 description 1
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Chemical & Material Sciences (AREA)
Developmental Biology & Embryology (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Cell Biology (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Rheumatology (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Virology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

TW099142522A 2009-12-04 2010-12-06 Mesenchymal stem cells (MSCs) isolated from mobilized peripheral blood TW201130977A (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
TW099142522A TW201130977A (en)	2009-12-04	2010-12-06	Mesenchymal stem cells (MSCs) isolated from mobilized peripheral blood

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US26682509P	2009-12-04	2009-12-04
TW99104520		2010-02-10
PCT/US2010/058980 WO2011069121A1 (fr)	2009-12-04	2010-12-03	Cellules souches mésenchymateuses (csm) isolées dans le sang périphérique mobilisé
TW099142522A TW201130977A (en)	2009-12-04	2010-12-06	Mesenchymal stem cells (MSCs) isolated from mobilized peripheral blood

Publications (1)

Publication Number	Publication Date
TW201130977A true TW201130977A (en)	2011-09-16

Family

ID=44115330

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW099142522A TW201130977A (en)	2009-12-04	2010-12-06	Mesenchymal stem cells (MSCs) isolated from mobilized peripheral blood

Country Status (2)

Country	Link
TW (1)	TW201130977A (fr)
WO (1)	WO2011069121A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN110402286A (zh) *	2017-11-28	2019-11-01	熊仲川	自周边血液制备间质干细胞群的方法及其用途

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102864123B (zh) *	2011-07-06	2015-04-22	北京大学第三医院	一种外周血间充质干细胞的获得方法及其应用
WO2013067038A1 (fr) *	2011-11-01	2013-05-10	Neostem, Inc.	Compositions de cellules souches mésenchymateuses adultes (msc) et procédés de préparation associés
US20130244948A1 (en) *	2012-03-15	2013-09-19	Scharp Technologies, Inc.	Compositions of cells, media, and methods thereof
EP2866816A4 (fr) *	2012-05-31	2016-03-16	Caladrius Biosciences Inc	Très petites cellules souches humaines de type embryonnaire dans le traitement de trouble oculaire
BE1020480A5 (nl) *	2012-10-01	2013-11-05	Global Stem Cell Technology	Werkwijze voor de isolatie van mesenchymale stamcellen uit bloed van zoogdieren, en gebruik ervan.
CA3206342A1 (fr)	2013-05-09	2014-11-13	Advanced Neuroregenerative Therapies, Llc	Facteur de croissance hematopoietique g-csf destine a etre utilise dans le traitement ou la prevention d'un dysfonctionnement lie a l'age ou d'une maladie immunitaire et de la senescence cellulaire
US20180161366A1 (en) *	2015-05-20	2018-06-14	Biokine Therapeutics Ltd.	Methods of obtaining mononuclear blood cells and uses thereof
US10786547B2 (en)	2015-07-16	2020-09-29	Biokine Therapeutics Ltd.	Compositions, articles of manufacture and methods for treating cancer
KR102033920B1 (ko)	2016-02-23	2019-10-18	바이오라인알엑스 리미티드	급성 골수성 백혈병을 치료하는 방법
EP3439610A4 (fr)	2016-04-06	2019-12-18	University of Florida Research Foundation, Inc.	Utilisation thérapeutique de cellules souches mésenchymateuses induites par électroacupuncture
EP3439674A4 (fr) *	2016-04-07	2019-11-27	Dragonfly Foundation For Research & Development Corp	Méthode et système permettant de réparer un tissu endommagé à l'aide de particules de plasma nucléées (nuc-p2s) et de cellules souches mésodermiques (mesosc)
WO2018187469A1 (fr) *	2017-04-05	2018-10-11	Senlin Li	Méthodes et compositions pour la transplantation de cellules souches non cytotoxiques
TR201911506A2 (tr) *	2019-07-30	2021-02-22	T C Erciyes Ueniversitesi	Trombosi̇tten zengi̇n fi̇bri̇n kaynakli mezenki̇mal kök hücreler
CN111671896B (zh) *	2020-07-31	2020-12-15	深圳迈吉赛尔生物科技有限公司	骨髓间充质干细胞和单克隆抗体联合治疗癌症的用途
IT202000030692A1 (it) *	2020-12-14	2022-06-14	Centro Di Riferimento Oncologico	Metodo per produrre cellule mesenchimali stromali staminali modificate con proprietà migliorate, cellule modificate ottenute con tale metodo, composizione che comprende tali cellule e loro uso.
WO2026054788A1 (fr) *	2024-09-04	2026-03-12	Giampapa Vincent C	Amélioration fonctionnelle sélective de cellules souches et/ou de leur matériau génétique, avec transfection génique pour le traitement à court et long terme d'états pathologiques liés à l'âge
US20260061075A1 (en) *	2024-09-04	2026-03-05	Vincent C. Giampapa	Selective functional enhancement of stem cells and or their genetic material, with gene transfection for short-and long-term treatment of age-related disease states

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7015037B1 (en) *	1999-08-05	2006-03-21	Regents Of The University Of Minnesota	Multiponent adult stem cells and methods for isolation
AUPR703601A0 (en) *	2001-08-15	2001-09-06	Peter Maccallum Cancer Institute, The	Identification and isolation of somatic stem cells and uses thereof
US20090004661A1 (en) *	2003-05-26	2009-01-01	Reliance Life Sciences Pvt Ltd.	Method of growing mesenchymal stem cells from bone marrow
US20080038231A1 (en) *	2006-06-15	2008-02-14	Rodgerson Denis O	Processing procedure for peripheral blood stem cells

2010
- 2010-12-03 WO PCT/US2010/058980 patent/WO2011069121A1/fr not_active Ceased
- 2010-12-06 TW TW099142522A patent/TW201130977A/zh unknown

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN110402286A (zh) *	2017-11-28	2019-11-01	熊仲川	自周边血液制备间质干细胞群的方法及其用途
CN110402286B (zh) *	2017-11-28	2023-05-26	熊仲川	自周边血液制备间质干细胞群的方法及其用途

Also Published As

Publication number	Publication date
WO2011069121A1 (fr)	2011-06-09

Publication	Publication Date	Title
TW201130977A (en)	2011-09-16	Mesenchymal stem cells (MSCs) isolated from mobilized peripheral blood
US7863043B2 (en)	2011-01-04	Stem cell populations and methods of use
WO2005063967A1 (fr)	2005-07-14	Technique pour induire la differenciation de cellules de moelle osseuse de mammiferes ou de cellules de sang de cordon ombilical en cellules myocardiques au moyen de tissu adipeux
JP2008504290A (ja)	2008-02-14	虚血の細胞ベースの治療
TW200804599A (en)	2008-01-16	Isolation and purification of hematopoietic stem cells from post-liposuction lipoaspirates
EP2214497A2 (fr)	2010-08-11	Utilisations et isolement de cellules souches de type embryonnaire très petites (vsel)
CA2705450A1 (fr)	2007-11-08	Cellules souches pour le traitement de maladies pulmonaires
US20080226612A1 (en)	2008-09-18	Compositions of Cells Enriched for Combinations of Various Stem and Progenitor Cell Populations, Methods of Use Thereof and Methods of Private Banking Thereof
KR102213527B1 (ko)	2021-02-09	패혈증 치료용 중간엽 기질세포
JP2015526065A (ja)	2015-09-10	超音波キャビテーションによる脂肪組織からの幹細胞の単離および使用方法
TW201130978A (en)	2011-09-16	Method of isolation of stem cell populations from peripheral blood using sized-based separation (elutriation)
KR20080042761A (ko)	2008-05-15	렙틴을 이용한 줄기세포 증식방법
EP1771551B1 (fr)	2011-01-05	Nouvelles populations cellulaires et utilisations de celles-ci
CN114901806B (zh)	2025-05-02	细胞群以及其取得方法
US20160158292A1 (en)	2016-06-09	Method and apparatus for recovery of umbilical cord tissue derived regenerative cells and uses thereof
CN113853206A (zh)	2021-12-28	脑梗塞的功能恢复
Wong et al.	2007	Evaluation of Sca-1 and c-Kit as selective markers for muscle remodelling by nonhemopoietic bone marrow cells
EP2205251B1 (fr)	2017-01-11	Procédé pour amplifier des cellules cardiaques souches in vitro et in vivo
CN104995295A (zh)	2015-10-21	多分化潜能细胞的制造方法
CN110882276B (zh)	2021-07-06	细胞治疗组合物及治疗血管病变的方法
CN110402286B (zh)	2023-05-26	自周边血液制备间质干细胞群的方法及其用途
CN101506353A (zh)	2009-08-12	外周造血干细胞的处理方法
US11674131B2 (en)	2023-06-13	Indirect ultrasonic cavitation-derived perivascular cells and methods of use thereof
RU2454247C1 (ru)	2012-06-27	Способ профилактики острой реакции трансплантат против хозяина после трансплантации аллогенного костного мозга
RU2800644C2 (ru)	2023-07-25	Способ получения фибробластов и г-ксф-положительная фибробластная масса